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Abstract
Deep sternal infections, also known as poststernotomy mediastinitis, are a rare but often fatal
complication in cardiac surgery. They are a cause of increased morbidity and mortality and have a
significant socioeconomic aspect concerning the health system. Negative pressure wound therapy
(NPWT) followed by muscular pectoralis plasty is a quite new technique for the treatment of
mediastinitis after sternotomy. Although it could be demonstrated that this technique is at least as
safe and reliable as other techniques for the therapy of deep sternal infections, complications are
not absent. We report about our experiences and complications using this therapy in a set of 54
patients out of 3668 patients undergoing cardiac surgery in our institution between January 2005
and April 2007.
Background
Poststernotomy mediastinitis or deep sternal infection
(DSI), is a serious cause of postoperative morbidity and
mortality in cardiac surgery patients. Its incidence is
reported to be between 1% and 3% and complications are
associated with a significant mortality between ranging
10% and 25% [1-3]. A wide range of wound-healing strat-
egies have been established until now for treatment of this
often devastating complication. Negative pressure wound
therapy was first introduced by Argenta and Morykwas
[4,5] and has become a widely used, efficacious and relia-
ble method for managing different types of open wounds
(e.g. abdomen, head, neck) after infection. In cardiac sur-
gery it is frequently applied for treating patients suffering
from deep sternal wound infections. Although greater ran-
domized controlled studies are missing, it is generally sug-
gested that it decreases morbidity and mortality associated
with DSI after thoracotomy. Recent publications have
shown promising results for this method [6,7]. However,
the strategy for surgical wound debridement is not stand-
ardised and varies significantly from surgeon to surgeon.
We analyzed our experiences and complications with 54
patients in our institution suffering from DSI between
January 2005 and April 2007 out of 3668 patients under-
going cardiac surgery procedures. The 54 patients were
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treated by NPWT and a subsequent pectoralis muscle
plasty for secondary closure. The observed complications
during their hospital-stay until discharge are reported.
Methods
We present an analysis of all consecutive patients suffering
from DSI after cardiac surgery between January 2005 and
April 2007 in our centre. All of these patients received
NPWT therapy for wound closure. They were suffering
from mediastinitis, partly with the involvement of the
sternum. Demographical data, general treatment and
patient outcomes were collected. Information was
retrieved according to hospital medical ethic committee.
Diagnosis of DSI is conducted by at least one of the fol-
lowing criteria: Isolation of a germ with infectious poten-
tial, demonstration of wound infection during
operational procedures or purulent discharge accompa-
nied with temperature above 38°C. The management of
cardiac patients referred with sternal wound complica-
tions were described previously [6]. The classification of
DSI is based on the international classification provided
by El Oakley and Wright [8]. The onsets of DSI as well as
the existence of specific risk factors for wound infections
are incorporated. The allocation system is presented in
table 1.
Results
There were 54 patients suffering from DSI in this period.
All patients were treated with NPWT therapy (see figure 1
and 2) and subsequent pectoralis muscle plasty for sec-
ondary wound closure. The result of successful wound
closure after pectoralis plasty is presented in figure 3. The
most frequently detected germ was staphylococcus epider-
mis (37.8%) followed by enterococcus faecilis (18.9%),
staphylococcus aureus (13.5%) and others (16.3). In
13.5% of all patients no bacteria could be detected.
According to the classification system by El Oakley et al.
[8] we classified the patients into seven groups. Most of
the patients encompassed a mediastinitis class IIIB
(33.3%) followed by class IIIA (25.9%). Less frequently
we observed mediastinitis class II (18.5%), class V
(11.1%), class IVB (5.6%), class I (3.7%) and class 4A
(1.9%).
Patient-related factors differ significantly between patients
developing DSI and those not developing DSI (table 2):
They were more often male, had higher body-weight, a
higher prevalence of diabetes and chronic obstructive pul-
monary disease (COPD). Notably, preoperative white
blood cell count and CRP-levels were equal in both
groups. Whereas intraoperative data did not differ signifi-
cantly from other patients, those patients who developed
DSI showed higher complication rates in the early postop-
erative course before detecting DSI (table 3): We noticed a
higher rate of reintubation and rethoracotomy, a lower
haemoglobin level and higher levels of white blood cell
counts in these cases. All of these patients had a prolonged
stay on ICU.
The predictive models identified well-known pre- and
postoperative risk factors for development of DSI (tables
2 and 4). In order to focus on intraoperative factors we
compared the predictive and observed incidence of DSI
for different types of operation (table 5) and also the sur-
geons (table 6), but were not able to find any intraopera-
tive risk factors. Notably, the use of bilateral mammary
arteries did not increase the risk for DSI.
Table 1: Classification of mediastinitis in patients undergoing cardiac surgery.
Class Description
Type I Mediastinitis presenting within 2 weeks after operation in the absence of risk factors
Type II Mediastinitis presenting at 2 to 6 weeks after operation in the absence of risk factors
Type IIIA Mediastinitis type I in the presence of one or more risk factors
Type IIIB Mediastinitis type II in the presence of one or more risk factors
Type IVA Mediastinitis type I, II, or III after one failed therapeutic trial
Type IVB Mediastinitis type I, II, or III after more than one failed therapeutic trial
Type V Mediastinitis presenting for the first time more than 6 weeks after operation
According to El Oakley and Wright [8] mediastinitis is defined as wound infection associated with sternal osteomyelitis with or without infected 
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The detection of DSI and subsequent treatment with
NPWT of the patients is clearly prolonged: the period of
time that patients stayed in hospital ranged from 22 days
up to 185 days (median 64.5 days). The time period from
Patient after bypass operation and deep sternal wound infec- tion treated in our hospital Figure 1
Patient after bypass operation and deep sternal 
wound infection treated in our hospital. The patient 
received NPWT before surgical approach for cleaning of the 
wound.
The figure shows the wound prior to refixation with pecto- ralis muscle already prepared for coverage of the sternum (a)  and with the pectoralis plasty in place Figure 2
The figure shows the wound prior to refixation with 
pectoralis muscle already prepared for coverage of 
the sternum (a) and with the pectoralis plasty in 
place.
The figure presents the complete closure of the wound after  NPWT therapy and pectoralis plasty Figure 3
The figure presents the complete closure of the 
wound after NPWT therapy and pectoralis plasty.Journal of Cardiothoracic Surgery 2009, 4:5 http://www.cardiothoracicsurgery.org/content/4/1/5
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the date of operation until detection of mediastinitis
ranged from 5 days to 155 days (19 days). Time period
from the start of the NPWT therapy until date of discharge
from hospital ranged from 7 days until 99 days with a
median at 35 days.
In addition complications occurred during the period
after detection of mediastinitis until discharge from hos-
pital (table 7): The most common complication was atrial
fibrillation followed by respiratory failure, other infec-
tions than sternal infections and rethoracotomy. In 74.1
percent of all patients no complication was reported
(table 6).
Pitfalls based mainly on the technical and surgical han-
dling during the procedure are the use of pressure lower
than 120 mm Hg that causes dismantling of the foil and
the need of subsequent debridement and revision of the
wound. In three cases we had to redo soft tissue recon-
struction unilateral, and patients necroses of the pectoralis
muscle because of loosening of muscular sutures. In four
cases the vacuum worked insufficiently because of a back-
flow of liquids into the tubes connecting the sealed
wound with the vacuum pump. The most serious compli-
cation was in one patient, who died due to rupture of the
right ventricle. After an uneventful course he abruptly
developed circulatory collapse after coughing with mas-
sive blood loss from the wound at the seventh day after
NPWT. Emergency thoracotomy revealed right ventricular
wall rupture by sharp sternal edges due to sternal instabil-
ity.
Table 2: Preoperative patient characteristics of patients developing DSI and control group
Patient characteristics, preoperative Mediastinitis group Control group P-value of univariate comparisons
Male gender 43 (81%) 3189 (69%) < 0,05
Age [years] 67,9 ± 1,4 67,8 ± 0,15 n.s.
Body height [cm] 168,7 ± 1,2 170 ± 0,12 n.s.
Body weight [kg] 88,9 ± 2,1 80,7 ± 0,2 < 0,001
Body-mass-index 31,3 ± 0,6 27,9 ± 0,07 < 0,001
Diabetes, oral 14 (26%) 851 (18%) < 0,05
Diabetes, insulin-dependent 12 (22%) 549 (12%) < 0,05
Ejection fraction [%] 54 ± 3,7 58 ± 0,4 n.s.
Hemoglobin, preoperative [g/dl] 13,5 ± 0,2 13,3 ± 0,02 n.s.
Hematocrit, preoperative [%] 40,3 ± 0,7 39,4 ± 0,1 n.s.
Leukocytes, preoperative [k/UL] 8,4 ± 0,7 7,8 ± 0,1 n.s.
Serum creatinine, preoperative [mg/dl] 1,2 ± 0,1 1,2 ± 0,01 n.s.
Creatinine kinase MB, preoperative [U/l] 21 ± 16,1 28,7 ± 2,0 n.s.
Chronic obstructive pulmonary disease 20 (38%) 918 (20%) <0,01
Reduced ejection fraction 24 (44%) 1620 (34%) P = 0,11
EuroSCORE 5,7 ± 0,4 5,9 ± 0,05 n.s.
CRP, preoperative [mg/l] 16,5 ± 3,9 11,4 ± 0,4 P = 0.19
According to El Oakley and Wright [8] mediastinitis is defined as wound infection associated with sternal osteomyelitis with or without infected 
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Comments
Although much progress has been made in the treatment
of postoperative infections, poststernotomy mediastinitis
or DSI is still a devastating complication of cardiac sur-
gery. Numerous studies have proven that an increase in
morbidity and mortality and a decrease in long-term sur-
vival are associated with mediastinitis after cardiac sur-
gery. Since it is also coupled with a longer hospital-stay
and an increment of nursing care, it has a considerable
economic impact to the health system [9,10].
In the classification system by El Oakley et al. only diabe-
tes, obesity and immunosuppressive therapies are risk fac-
tors for this complication. Using this classification system
one third of our patients had no risk factor and 70 percent
had one or more risk factors. Other risk factors found in
the literature for the development of a postoperative
mediastinitis include higher age, malnutrition, smoking
etc. [2]. Beside the management of metabolic factors
(especially diabetes), other risk factors identified in our
study e.g. COPD and obesity may also reflect the higher
mechanical forces present in these patients leading to
instability of the sternum. In these cases special tech-
niques of sternum closures e.g. the use of double armed
wires are an alternative. Although we could not prove an
impact of the individual surgeon on the incidence of DSI,
the fact that one surgeon had no incidence of DSI in more
than 200 patients may also reflect an adequate technique
of chest opening and closure. The careful use of electro-
cautery, the complete closure of the fascia, the use of sin-
gle sutures of the fascia and the skin in exposed patients
may help to prevent DSI. It was obvious in our study how
the incidence of DSI depend on major postoperative com-
plication like reintubation and rethoracotomy.
Treatment of DSI using NPWT is described since 10 years
[11]. Since then more than 400 cases have been published
describing NPWT as suitable therapy for deep sternal
wounds after cardiac surgery. NPWT therapy is known to
increase the capillary diameter, the blood flow velocity
Table 3: Intra- and postoperative patient characteristics of patients developing DSI and control group
Indicators of course after major cardiac surgery Mediastinitis group Control group P-value of univariate comparisons
Double internal mammary arteries 13 (24%) 1112 (23%) n.s.
Pump time [min] 94,5 ± 7,3 81,2 ± 0,8 = 0,06
Aortic clamp time 68 ± 4,9 57 ± 0,51 <0,05
Operation time 207 ± 8,1 192,2 ± 0,9 = 0,06
Postoperative stay [days] 33 ± 1 7,0 ± 0,1 < 0,001
Atrial fibrillation, postoperative 30 (56%) 2042 (43%) P = 0.06
Reintubation 19 (35%) 193 (4%) < 0,001
Pleural effusions 24 (44%) 1998 (42%) n.s.
Rethorakotomy 7 (13%) 113 (2,3%) < 0,001
Hemoglobin, 6 h postoperative [g/dl] 10,5 ± 0,2 10,4 ± 0,16 n.s.
Hemoglobin, discharge [g/dl] 10,5 ± 0,2 11,2 ± 0,02 < 0,001
Erythrocytes, minimum during stay [g/dl] 2,8 ± 0,05 3,0 ± 0,01 < 0,001
Leukocytes, 6h postoperative [k/UL] 10,7 ± 0,8 10,0 ± 0,1 n.s.
Leukocytes, maximum postoperative [k/UL] 17,6 ± 1,1 14,3 ± 0,1 < 0,01
Serumcreatinine, postoperative [mg/dl] 2,4 ± 0,15 1,6 ± 0,02 < 0,001
Higher serum sodium postoperative [mmol/l] 145,9 ± 0,5 143,7 ± 0,05 < 0,001Journal of Cardiothoracic Surgery 2009, 4:5 http://www.cardiothoracicsurgery.org/content/4/1/5
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and to stimulate angiogenesis and endothelial cell prolif-
eration and thereby promoting tissue proliferation and
wound closure [12]. In most of the cases, NPWT therapy
was used as a "bridge to surgery therapy" in contaminated
wounds. This term describes very well the approach which
is used in our clinic. It was reported that NPWT facilitates
a better mobilisation of patients compared to other strat-
egies [13]. Depending on the extent of the wound,
patients are able to sit, to perform pulmonary exercises
and to walk. The change of the NPWT sponges in our hos-
pital is always performed in OR, in most cases after two to
three days, depending on the status of the wound and lab-
oratory results. We have no standard scheme which is
applied to every patient. The concept of NPWT has been
applied and published in cases of post-sternotomy medi-
astinitis and showed promising results. Sjögren et al. [11]
presented a 90-day mortality of 0% in a group of 53 pts.
The group identified the time interval from cardiac sur-
gery to diagnosis of deep sternal wound infection and the
duration of wound therapy as independent predictors for
late mortality. Prolonged use of NPWT appeared to be
associated with recurrent infection and problems of the
sternal wound in another publication with 21 patients
with DSWI by Bapat et al. [14] In deep sternal infections
after cardiac surgery they recommend NPWT therapy for a
rather short period of time followed by early surgical clo-
sure if it seems sensible in the context [14].
In our hospital all patients suffering from DSI were treated
with aggressive debridement of the wound and a subse-
Table 4: Multivariate risk factors for postoperative mediastinitis
Term Estimate Std Error P-value Odds Ratio
Intercept 6,01 1,48 < 0,001
Chronic obstructive pulmonary disease 0,35 0,15 0,02 2,01
Rethoracotomy (other than wound infection) 0,30 0,25 0,23 1,82
Reintubation 1,14 0,17 < 0,001 9,79
Higher Body mass index -0,14 0,02 < 0,001 0,00
More red cell package postop -0,03 0,02 0,19 0,10
Lower haemoglobin at discharge 0,19 0,11 0,09 7,15
Male gender -0,45 0,19 0,02 0,41
Higher creatinine postoperative -0,16 0,09 0,08 0,14
Table 5: No significant differences between types of operation were observed (ANOVA)
Type of Surgery N Expected risk for mediastinits [%] Observed incidence of mediasitnitis [%] Observed/Expected
On-PCAB 1671 1,1 1,6 1,4
O(ff)-PCAB 917 1,0 0,4 0,4
Valve&CABG 710 1,3 1,7 1,3
Aortic surgery 229 1,2 0,4 0,1
Isolated Valves 2582 1,1 1,2 1,0
Double valves 76 1,1 1,3 4,2
Re-do valves 106 1,5 0,9 0,2
Miscellaneous 174 1,1 1,7 1,7Journal of Cardiothoracic Surgery 2009, 4:5 http://www.cardiothoracicsurgery.org/content/4/1/5
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quent NPWT therapy followed by pectoralis muscle plasty
for secondary wound closure as previously described by
our group [6].
In our experience wire removal and debridement should
be undertaken as early as possible and should be per-
formed in the operating theatre with a CBP capability and
not as a bedside procedure. Sternal instability is the main
cause for complications in postoperative therapies using
negative pressure wound therapy. A restabilization of the
sternum is absolutely necessary because of the possibility
of mechanical alteration of the sternum that may lead to
injuries of tissues underneath the sternum as observed in
the described case of the patient who died.
For this complication of right ventricular rupture using
NPWT only very few cases have been described until now
[15]. In most of the cases the rupture occurred because of
insufficient numbers of paraffin layers or insufficient
placement of the layers. In other known cases where ven-
tricular rupture occurred, it happened because of direct
contact of the foam or the sternum with the underlying
ventricle [16]. However, it might be speculated that some
additional fatal events do not have been reported. These
findings fit with our observation that the most common
complication during the hospital stay of the analyzed
patients is caused by the loss of sternal fixation or break-
ing of the cerclages. Other complications reported are few.
There is one report about a retained piece of sponge [17],
and reports about ventricle ruptures caused by direct con-
tact of the sharp edges of the loosen sternum with tissues
underneath as in our case [15].
In line with other publications [18-20] we recommend
NPWT for infected wounds from small to large extent after
cardiac surgery. To our knowledge there is no therapeuti-
cally concept which offers a similar "bridge to surgery"
treatment with successful healing rates. In addition to
this, patient mobilisation, pulmonary therapy and general
nursing care improved in our hospital since the applica-
tion of negative pressure wound therapy.
Conclusion and future outlook
In line with the mentioned articles and reviews we come
to the conclusion, that negative pressure wound treatment
is a relatively new option for treatment of devastating
wounds after sternotomy in cardiac surgery. As many
institutions have presented their own approaches, it is
important to find a strategy which may be used as a
"standard NPWT approach" if identified in the future. It is
therefore necessary to share our knowledge and experi-
ences and to find an optimum treatment for these seri-
ously ill patients in a consensus or algorithm e.g.
proposed by the Lund University Hospital [21].
Table 6: No significant differences between the surgeons were observed (ANOVA)
Surgeons N Expected risk for mediastinits [%] Observed incidence of mediasitnitis [%] Observed/Expected
Surg. A 331 1,2 1,2 1,0
Surg. B 294 1,0 1,7 1,6
Surg. C 746 1,1 0,7 0,6
Surg. D 685 1,3 1,3 1,0
Surg. E 205 1,4 0,0 0,0
Surg. F 921 1,0 1,0 0,9
Surg. G 576 1,2 1,4 1,1
Trainees 1031 1,1 1,2 1,1
Table 7: Complications occurred during NPWT
Complication Number/ Percent
Instable sternum 1 1.9
Infection other than Mediastinitis 2 3.7
Respiratory failure 4 7.4
Atrial fibrillation 5 9.3
Re-Thoracotomy 1 1.9
Rupture of the right ventricle 1 1.9
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